Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Metastatic gpNMB Expressing Triple Negative Breast Cancer × Breast × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Metastatic gpNMB Expressing Triple Negative Breast Cancer 1 Melanoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Brain Neoplasms 1 Advanced Breast Cancer (Female) 1

Interventions

glembatumumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

Celldex Therapeutics

No longer available

Metastatic gpNMB Expressing Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡